K

Double Point Ventures logo

Double Point Ventures

Crunchbase
Pitchbook
Crunchbase

Deals on record

3

Common Fundraising Type

Series B

Umoja Biopharma logo
Umoja Biopharma

Biotechnology • In vivo cell therapies

University of Minnesota Endowment logo
SoftBank logo
RTW Investments logo
Qiming Venture Partners USA logo

Umoja Biopharma is a biotechnology company focused on developing in vivo CAR T cell therapies for oncology and autoimmune diseases using its VivoVec™ gene delivery technology.

Series C
$100M
01/20/2025
Article
GEMMABio logo
GEMMABio

Gene therapy • Rare diseases

GEMMA Biotherapeutics is a therapeutics company focused on advancing gene therapy research and expanding access to therapies for rare diseases.

Seed
$34M
12/23/2024
Article
DermBiont logo
DermBiont

Biotechnology • Dermatology

Double Point Ventures logo
Viking Global Investors logo
Olive Tree Capital logo
Civilization Ventures logo

DermBiont is a clinical-stage biotechnology company that develops targeted topical therapeutics for dermatological indications, with a focus on treating seborrheic keratoses and melasma.

Series B
$35.2M
10/24/2023
Article